(Q43450686)

23 November 2017

Pregabalin augmentation of antidepressants in older patients with comorbid depression and generalized anxiety disorder-an open-label study (English)

1 reference

23 November 2017

1 reference

ChEBI release 2020-05-28

Dimitrios Karaiskos

1

1 reference

23 November 2017

Dimitra Pappa

2

1 reference

23 November 2017

Elias Tzavellas

3

1 reference

23 November 2017

Kostas Siarkos

4

1 reference

23 November 2017

Everina Katirtzoglou

5

1 reference

23 November 2017

George N Papadimitriou

6

1 reference

23 November 2017

Antonios Politis

7

1 reference

23 November 2017

language of work or name

English

0 references

publication date

20 March 2012

1 reference

International Journal of Geriatric Psychiatry

23 November 2017

1 reference

23 November 2017

28

1 reference

23 November 2017

100-105

1 reference

23 November 2017

1

1 reference

Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis

23 November 2017

1 reference

Anxiety and depression in later life: Co-occurrence and communality of risk factors.

21 January 2018

1 reference

High occurrence of mood and anxiety disorders among older adults: The National Comorbidity Survey Replication

21 January 2018

1 reference

Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy

21 January 2018

1 reference

21 January 2018

1 reference

An effect-size analysis of pharmacologic treatments for generalized anxiety disorder

21 January 2018

1 reference

Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder

21 January 2018

1 reference

An analysis of correlations among four outcome scales employed in clinical trials of patients with major depressive disorder

21 January 2018

1 reference

Comorbidity of depressive and anxiety disorders for older Americans in the national comorbidity survey-replication.

21 January 2018

1 reference

Age- and gender-specific prevalence of depression in latest-life--systematic review and meta-analysis.

21 January 2018

1 reference

Risks for depression onset in primary care elderly patients: potential targets for preventive interventions

21 January 2018

1 reference

Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder.

21 January 2018

1 reference

Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder

21 January 2018

1 reference

Pharmacology profile and clinical findings of pregabalin (Lyrica capsule)

21 January 2018

1 reference

Association of depression with subsequent mortality, cardiovascular morbidity and incident dementia in people aged 80 and over and suffering from hypertension. Data from the Hypertension in the Very Elderly Trial (HYVET).

21 January 2018

1 reference

High prevalence and prescription of benzodiazepines for elderly: data from psychiatric consultation to patients from an emergency room of a general hospital.

21 January 2018

1 reference

Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies

21 January 2018

1 reference

Pregabalin for generalised anxiety disorder

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

A meta-analysis of the efficacy of pregabalin in the treatment of generalized anxiety disorder

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/GPS.3800

1 reference

23 November 2017

1 reference